Claire Giraut has served as a member of DBV’s board of directors since 2016. Up until April 2018, Ms. Giraut was Executive Vice President, Chief Financial Officer of bioMérieux, a global leader in in vitro diagnostics, a position she held since 2013. She previously served as Chief Financial Officer of Ipsen, a global specialty-driven pharmaceutical group, from 2003 to 2011 and as Chief Financial Officer of Europcar, after holding various finance leadership positions in other worldwide organizations. Since 2010, she has also been serving as a director of Julius Baer Group Ltd., the leading Swiss private banking group. Ms. Giraut holds a master’s degree from the Institut National Agronomique (AgroParisTech) in Paris.